183 related articles for article (PubMed ID: 30083980)
21. Genome-wide pathway analysis for diabetic nephropathy in type 1 diabetes.
Lee YH; Song GG
Endocr Res; 2016; 41(1):21-7. PubMed ID: 26167956
[TBL] [Abstract][Full Text] [Related]
22. Novel Genetic Actors of Diabetes-Associated Microvascular Complications: Retinopathy, Kidney Disease and Neuropathy.
Davoudi S; Sobrin L
Rev Diabet Stud; 2015; 12(3-4):243-59. PubMed ID: 26859656
[TBL] [Abstract][Full Text] [Related]
23. Genetic associations in diabetic nephropathy.
Mooyaart AL
Clin Exp Nephrol; 2014 Apr; 18(2):197-200. PubMed ID: 24129556
[TBL] [Abstract][Full Text] [Related]
24. The genetic side of diabetic kidney disease: a review.
Song J; Ni J; Yin X
Int Urol Nephrol; 2023 Feb; 55(2):335-343. PubMed ID: 35974289
[TBL] [Abstract][Full Text] [Related]
25. Hyperuricemia contributes to the faster progression of diabetic kidney disease in type 2 diabetes mellitus.
Bartáková V; Kuricová K; Pácal L; Nová Z; Dvořáková V; Švrčková M; Malúšková D; Svobodová I; Řehořová J; Svojanovský J; Olšovský J; Bělobrádková J; Kaňková K
J Diabetes Complications; 2016; 30(7):1300-7. PubMed ID: 27324705
[TBL] [Abstract][Full Text] [Related]
26. Genome-wide studies to identify risk factors for kidney disease with a focus on patients with diabetes.
Regele F; Jelencsics K; Shiffman D; Paré G; McQueen MJ; Mann JF; Oberbauer R
Nephrol Dial Transplant; 2015 Aug; 30 Suppl 4():iv26-34. PubMed ID: 26209735
[TBL] [Abstract][Full Text] [Related]
27. Association of chemotactic cytokine receptor 5 (CCR5) gene polymorphism (59029 A/G, rs1799987) with diabetic kidney disease in patients with type 2 diabetes from Poland.
Pokrzywnicka P; Kwiendacz H; Nabrdalik K; Hajzler W; Adamczyk P; Moczulski D; Trautsolt W; Grzeszczak W; Gumprecht J
Endokrynol Pol; 2022; 73(1):103-109. PubMed ID: 35119091
[TBL] [Abstract][Full Text] [Related]
28. No prognostic role of a GWAS-derived genetic risk score in renal outcomes for patients from French cohorts with type 1 and type 2 diabetes.
Barbieux P; György B; Gand E; Saulnier PJ; Ducrocq G; Halimi JM; Feigerlova E; Hulin-Delmotte C; Llaty P; Montaigne D; Rigalleau V; Roussel R; Sosner P; Zaoui P; Ragot S; Marre M; Tregouët DA; Hadjadj S; ;
Diabetes Metab; 2019 Oct; 45(5):494-497. PubMed ID: 29540294
[No Abstract] [Full Text] [Related]
29. Genetic and Epigenetic Studies in Diabetic Kidney Disease.
Gu HF
Front Genet; 2019; 10():507. PubMed ID: 31231424
[TBL] [Abstract][Full Text] [Related]
30. Multidisciplinary management of diabetic kidney disease: a systematic review and meta-analysis.
Helou N; Dwyer A; Shaha M; Zanchi A
JBI Database System Rev Implement Rep; 2016 Jul; 14(7):169-207. PubMed ID: 27532796
[TBL] [Abstract][Full Text] [Related]
31. Genetic factors in diabetic nephropathy.
Freedman BI; Bostrom M; Daeihagh P; Bowden DW
Clin J Am Soc Nephrol; 2007 Nov; 2(6):1306-16. PubMed ID: 17942768
[TBL] [Abstract][Full Text] [Related]
32. The impact of mitochondrial quality control by Sirtuins on the treatment of type 2 diabetes and diabetic kidney disease.
Xu J; Kitada M; Koya D
Biochim Biophys Acta Mol Basis Dis; 2020 Jun; 1866(6):165756. PubMed ID: 32147421
[TBL] [Abstract][Full Text] [Related]
33. Genetic susceptibility to diabetic kidney disease: an update.
Krolewski AS; Warram JH
J Diabetes Complications; 1995; 9(4):277-81. PubMed ID: 8573746
[TBL] [Abstract][Full Text] [Related]
34. Assessing genetic susceptibility to diabetic nephropathy.
Tanaka N; Babazono T
Nephrology (Carlton); 2005 Oct; 10 Suppl():S17-21. PubMed ID: 16174281
[TBL] [Abstract][Full Text] [Related]
35. T2D-nephropathy linkage within 12q24 locus.
Gragnoli C
Diabetes Res Clin Pract; 2011 Jun; 92(3):e73-5. PubMed ID: 21439668
[TBL] [Abstract][Full Text] [Related]
36. Genetics of diabetic nephropathy in diverse ethnic groups.
Brorsson C; Pociot F
Contrib Nephrol; 2011; 170():8-18. PubMed ID: 21659753
[TBL] [Abstract][Full Text] [Related]
37. Towards understanding the inherited susceptibility for nephropathy in diabetes.
Thomas MC; Groop PH; Tryggvason K
Curr Opin Nephrol Hypertens; 2012 Mar; 21(2):195-202. PubMed ID: 22314557
[TBL] [Abstract][Full Text] [Related]
38. Genetics of diabetes-associated microvascular complications.
Lyssenko V; Vaag A
Diabetologia; 2023 Sep; 66(9):1601-1613. PubMed ID: 37452207
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of Serum microRNAs in Patients with Diabetic Kidney Disease: A Nested Case-Controlled Study and Bioinformatics Analysis.
Regmi A; Liu G; Zhong X; Hu S; Ma R; Gou L; Zafar MI; Chen L
Med Sci Monit; 2019 Mar; 25():1699-1708. PubMed ID: 30835718
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of associations between single nucleotide polymorphisms in the FRMD3 and CARS genes and diabetic nephropathy in a Kuwaiti population.
Al-waheeb S; Alwohhaib M; Abdelghani A; Al-Sharrah S; Al-Shafey E; Al-Sahow A; Alyatama N; Dashti AA; Hussain N
Genet Mol Res; 2016 Jan; 15(1):. PubMed ID: 26909942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
